ACADIA Pharmaceuticals (NASDAQ:ACAD) Raised to Buy at StockNews.com
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday. Several other research analysts also recently commented on ACAD. HC Wainwright reiterated a “buy” rating and issued a $27.00 price objective on shares […]
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday. Several other research analysts also recently commented on ACAD. HC Wainwright reiterated a “buy” rating and issued a $27.00 price objective on shares […]
